Adoption of advanced genotyping technologies in Countries like Japan, China, and Australia Serve as Major Revenue Pockets for the High-Resolution Melting Analysis Market

Based on product and service, the global high-resolution melting analysis market is divided into instruments, reagents & consumables, and software & services. The reagents and consumables segment dominated the market in 2016. The large share of this segment can be attributed to the increasing genotyping test volumes, the availability of an increased variety of reagents, and the need for reliable & specific reagents & kits.

Based on application, the high-resolution melting analysis market is segmented into SNP genotyping, mutation discovery, species identification, pathogen identification, epigenetics, and other applications (HLA compatibility typing, zygosity testing, DNA fingerprinting, DNA mapping, association (case/control) studies, allelic prevalence in a population, and identification of candidate predisposition genes). The SNP genotyping segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to the increasing use of genotyping to predict the efficiency of drugs during drug development, study variations in drug responses, and identify genetic variation in plant/animal genome.

On the basis of end user, the high-resolution melting analysis market is segmented into research laboratories & academic institutes, hospitals & diagnostics centers, pharmaceutical & biotechnology companies, and other end users. In 2016, the research laboratories & academic institutes segment accounted for the largest share of the global high-resolution melting analysis market. This can be attributed to growing industry-academia collaborations in the field of qPCR-based genomic research, increasing government support for genome-based research (particularly in disease therapies and drug discovery), and the development of cost-effective and innovative qPCR products.

The Asia-Pacific region presents huge opportunities for the growth of the high-resolution melting analysis market owing to its large patient population, growth in aging population, improving healthcare infrastructure, growing per capita income, expansion of key market players in this region, and increasing awareness of personalized medicine. Market growth is expected to be aided by efforts to increase awareness related to gene-based disease diagnosis and treatment, growing public and private-sector support to develop novel genetic scanning technologies, growth in the Indian genomics market, and advancing cancer research in Japan. Additionally, several global life sciences companies are striving to expand their market presence in APAC through strategic initiatives such as collaborations, partnerships, agreements, and capacity enhancement (including R&D and manufacturing facilities).


What Next?

Recent Articles